ICLR
- ICON PLC
()
Overview
Company Summary
ICON PLC is a global contract research organization (CRO) that provides various services to the pharmaceutical, biotechnology, and medical device industries. As a CRO, ICON acts as a strategic partner for its clients, helping them in the development, management, and analysis of clinical trials and other research projects.
ICON offers a wide range of services throughout the entire drug development process. This includes early phase research, where they assist in the design and execution of clinical trials to determine the safety, tolerability, and pharmacokinetics of a drug candidate. ICON also works on late-phase trials, which focus on testing the drug's effectiveness and monitoring its safety on a larger patient population.
In addition to clinical trial management, ICON provides various other services related to data management, bioanalytics, strategic consulting, regulatory and pharmacovigilance support, patient recruitment, and market access. The company uses advanced technologies, such as artificial intelligence, to optimize trial design, data collection, and analysis, thereby accelerating the development timeline and reducing costs for their clients.
ICON works collaboratively with pharmaceutical and biotechnology companies, academia, government agencies, and healthcare organizations worldwide. Their goal is to assist their clients in bringing safe and effective medicines to market efficiently and successfully, ultimately improving patient outcomes and advancing healthcare globally.